OTC Prilosec For Chronic Use Needs Explicit Labeling, NDAC, GDAC Advise
This article was originally published in The Tan Sheet
Executive Summary
Chronic use of OTC Prilosec (omeprazole) may benefit patients with gastroesophageal reflux disease provided labeling explicitly lists appropriate warnings, advisory committee members concluded at a switch review for the heartburn drug.
You may also be interested in...
Prilosec 1 Switch For Heartburn Prevention, 14-Day Use To Be Considered
OTC omeprazole will return for a second FDA advisory committee review June 21 with a revised indication and recommended duration of use
Prilosec 1 Switch For Heartburn Prevention, 14-Day Use To Be Considered
OTC omeprazole will return for a second FDA advisory committee review June 21 with a revised indication and recommended duration of use
Prilosec 1 Switch For Heartburn Prevention, 14-Day Use To Be Considered
OTC omeprazole will return for a second FDA advisory committee review June 21 with a revised indication and recommended duration of use